- Home
- KXIN vs KTTA Comparison
KXIN vs KTTA Comparison
Compare KXIN & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- KTTA
- Stock Information
- Founded
- KXIN 2015
- KTTA 2020
- Country
- KXIN China
- KTTA United States
- Employees
- KXIN N/A
- KTTA N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- KXIN Consumer Discretionary
- KTTA Health Care
- Exchange
- KXIN Nasdaq
- KTTA Nasdaq
- Market Cap
- KXIN 3.1M
- KTTA 3.4M
- IPO Year
- KXIN N/A
- KTTA 2021
- Fundamental
- Price
- KXIN $1.76
- KTTA $2.64
- Analyst Decision
- KXIN
- KTTA
- Analyst Count
- KXIN 0
- KTTA 0
- Target Price
- KXIN N/A
- KTTA N/A
- AVG Volume (30 Days)
- KXIN 735.2K
- KTTA 57.8K
- Earning Date
- KXIN 11-26-2019
- KTTA 11-13-2024
- Dividend Yield
- KXIN N/A
- KTTA N/A
- EPS Growth
- KXIN N/A
- KTTA N/A
- EPS
- KXIN N/A
- KTTA N/A
- Revenue
- KXIN $12,679,000.00
- KTTA N/A
- Revenue This Year
- KXIN N/A
- KTTA N/A
- Revenue Next Year
- KXIN N/A
- KTTA N/A
- P/E Ratio
- KXIN N/A
- KTTA N/A
- Revenue Growth
- KXIN N/A
- KTTA N/A
- 52 Week Low
- KXIN $1.66
- KTTA $2.52
- 52 Week High
- KXIN $64.80
- KTTA $9.40
- Technical
- Relative Strength Index (RSI)
- KXIN 36.41
- KTTA 34.15
- Support Level
- KXIN $1.66
- KTTA $2.57
- Resistance Level
- KXIN $1.96
- KTTA $3.07
- Average True Range (ATR)
- KXIN 0.15
- KTTA 0.21
- MACD
- KXIN 0.18
- KTTA 0.01
- Stochastic Oscillator
- KXIN 19.63
- KTTA 14.49
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.